Literature DB >> 11601142

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.

J D Studt1, U Budde, R Schneppenheim, R Eisert, M von Depka Prondzinski, A Ganser, M Barthels.   

Abstract

The analysis of von Willebrand factor (vWF) multimers is an important laboratory tool for distinguishing among the numerous subtypes of von Willebrand disease (vWD). Comparability and reproducibility of this method are insufficient; standardization and external references are pending. Interlaboratory comparison of results therefore may be difficult. We applied densitometry to obtain a reproducible quantification of vWF multimer patterns in healthy donors, patients with vWD variants, and factor VIII/vWF concentrates to improve the reproducibility and comparability of vWF multimer analysis. Multimers were separated and visualized luminographically on x-ray films. Films were scanned and evaluated by densitometry. The variation inherent in vWF multimer analysis and the range of the normal could be quantified. In vWD variants and factor VIII/vWF concentrates, densitometry could quantify and visualize alterations of vWF multimer patterns and facilitate their comparison. Densitometry permits a precise quantitative comparison of sample patterns to a reference plasma. It could be a valuable tool offering reproducible quantification and additional visualization of normal and pathologic vWF multimer patterns, facilitating their comparison and contributing to a standardization of vWF multimer analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601142     DOI: 10.1309/75CQ-V7UX-4QX8-WXE7

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.

Authors:  Donna Mancini; Juan Monteagudo; Mayte Suárez-Fariñas; Jeffrey Bander; Rohan Varshney; Juana Gonzalez; Barry S Coller; Jasimuddin Ahamed
Journal:  Transl Res       Date:  2017-11-05       Impact factor: 7.012

2.  Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.

Authors:  Rahel Froehlich-Zahnd; James N George; Sara K Vesely; Deirdra R Terrell; Khatira Aboulfatova; Jing-Fei Dong; Brenda M Luken; Jan Voorberg; Ulrich Budde; Irmela Sulzer; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

Review 3.  Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.

Authors:  Joseph L Blackshear
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03

4.  Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia.

Authors:  Suba Krishnan; Jamie Siegel; Gene Pullen; Megan Hevelow; Carlton Dampier; Marie Stuart
Journal:  Thromb Res       Date:  2008-01-29       Impact factor: 3.944

5.  Von Willebrand disease: an overview.

Authors:  K Pavani Bharati; U Ram Prashanth
Journal:  Indian J Pharm Sci       Date:  2011-01       Impact factor: 0.975

6.  Von Willebrand Factor Multimers and the Relaxation Response: A One-Year Study.

Authors:  Carlo Dal Lin; Laura Acquasaliente; Sabino Iliceto; Vincenzo De Filippis; Giuseppe Vitiello; Francesco Tona
Journal:  Entropy (Basel)       Date:  2021-04-10       Impact factor: 2.524

7.  Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.

Authors:  Ishac Nazy; Stefan D Jevtic; Jane C Moore; Angela Huynh; James W Smith; John G Kelton; Donald M Arnold
Journal:  J Thromb Haemost       Date:  2021-03-14       Impact factor: 16.036

8.  Establishing reference intervals for von Willebrand factor multimers.

Authors:  Marika Pikta; Marc Vasse; Kristi J Smock; Karen A Moser; Dievoet Marie-Astrid van; Sandra Lejniece; Timea Szanto; Hector Bautista; George Nouadje; Valdas Banys
Journal:  J Med Biochem       Date:  2022-02-02       Impact factor: 3.402

9.  Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers.

Authors:  Annette E Bowyer; Karen J Goodfellow; Holger Seidel; Philipp Westhofen; Francesca Stufano; Anne Goodeve; Stephen Kitchen; Michael Makris
Journal:  Res Pract Thromb Haemost       Date:  2018-08-12

10.  Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease.

Authors:  Johan Boender; Ferdows Atiq; Marjon H Cnossen; Johanna G van der Bom; Karin Fijnvandraat; Joke de Meris; Moniek P M de Maat; Karin P M van Galen; Britta A P Laros-van Gorkom; Karina Meijer; Jeroen Eikenboom; Frank W G Leebeek
Journal:  Hemasphere       Date:  2021-02-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.